One Ascent Financial Services LLC Sarepta Therapeutics, Inc. Transaction History

One Ascent Financial Services LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 27, 2021	SELL	$72.25 - $168.95 $111,265 - $260,182	-1,540 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$125.56 - $178.74 $230,904 - $328,702	-1,839 Reduced 54.42%	1,540 $263,000
Q4 2020 Jan 13, 2021	BUY	$125.56 - $178.74 $16,699 - $23,772	133 Added 4.1%	3,379 $576,000
Q3 2020 Nov 02, 2020	BUY	$127.12 - $172.34 $72,966 - $98,923	574 Added 21.48%	3,246 $456,000
Q2 2020 Jul 21, 2020	SELL	$93.0 - $171.7 $35,340 - $65,245	-380 Reduced 12.45%	2,672 $428,000
Q1 2020 Apr 14, 2020	SELL	$82.38 - $131.64 $120,110 - $191,931	-1,458 Reduced 32.33%	3,052 $299,000
Q4 2019 Feb 11, 2020	BUY	$76.53 - $135.58 $345,150 - $611,465	4,510 New	4,510 $582,000
Q3 2019 Nov 15, 2019	SELL	$72.81 - $156.91 $236,996 - $510,742	-3,255 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$112.21 - $151.95 $365,243 - $494,597	3,255 New	3,255 $495,000

529

84.1M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of One Ascent Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on One Ascent Financial Services LLC with notifications on news.